Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Gynecology

Free Subscription Articles published in Cancer Retrieve available abstracts of 49 articles: HTML format

Single Articles

April 2023
1. NIERENGARTEN MB
   Balancing the benefits and harms of cervical cancer screening in older women.
   Cancer. 2023;129:979-980.
   PubMed    
   
   
   March 2023
2. FOSTER KI, Shaw KRM, Jin J, Westin SN, et al
   Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.
   Cancer. 2023 Mar 17. doi: 10.1002/cncr.34724.
   PubMed     Abstract available
   
   
   
3. METCALFE KA, Gronwald J, Tung NM, McCuaig JM, et al
   The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
   Cancer. 2023;129:901-907.
   PubMed     Abstract available
   
   
   
4. CHINO JP, Moss HA, Swartz JJ, Gray BA, et al
   Care of the pregnant patient with cancer should include unfettered access to abortion.
   Cancer. 2023 Mar 12. doi: 10.1002/cncr.34686.
   PubMed    
   
   
   
5. NGUYEN T, Bhosale PR, Cassia L, Surabhi V, et al
   Malignancy in pregnancy: Multimodality imaging and treatment.
   Cancer. 2023 Mar 12. doi: 10.1002/cncr.34688.
   PubMed     Abstract available
   
   
   
6. HENDRIKSE CSE, van der Ploeg P, van de Kruis NMA, Wilting JHC, et al
   Functional estrogen receptor signal transduction pathway activity and antihormonal therapy response in low-grade ovarian carcinoma.
   Cancer. 2023 Mar 3. doi: 10.1002/cncr.34661.
   PubMed     Abstract available
   
   
   
7. GRISHAM RN, Manning-Geist BL, Chui MH
   Beyond the estrogen receptor: In search of predictive biomarkers for low-grade serous ovarian cancer.
   Cancer. 2023 Mar 3. doi: 10.1002/cncr.34658.
   PubMed    
   
   
   
8. NIERENGARTEN MB
   FDA grants accelerated approval for targeted therapy for platinum-resistant gynecologic cancers.
   Cancer. 2023;129:656.
   PubMed    
   
   
   February 2023
9. HYDE ET, LaCroix AZ, Evenson KR, Howard AG, et al
   Accelerometer-measured physical activity and postmenopausal breast cancer incidence in the Women's Health Accelerometry Collaboration.
   Cancer. 2023 Feb 22. doi: 10.1002/cncr.34699.
   PubMed     Abstract available
   
   
   January 2023
10. BEN-ARYE E, Segev Y, Galil G, Marom I, et al
    Acupuncture during gynecological oncology surgery: A randomized controlled trial assessing the impact of integrative therapies on perioperative pain and anxiety.
    Cancer. 2023 Jan 17. doi: 10.1002/cncr.34542.
    PubMed     Abstract available
    
    
    
11. PODWIKA SE, Duska LR
    Top advances of the year: Cervical cancer.
    Cancer. 2023 Jan 7. doi: 10.1002/cncr.34617.
    PubMed     Abstract available
    
    
    December 2022
12. KANG EY, Weir A, Meagher NS, Farrington K, et al
    CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.
    Cancer. 2022 Dec 26. doi: 10.1002/cncr.34582.
    PubMed     Abstract available
    
    
    October 2022
13. LUTGENDORF SK, Thaker PH, Goodheart MJ, Arevalo JMG, et al
    Biobehavioral factors predict an exosome biomarker of ovarian carcinoma disease progression.
    Cancer. 2022 Oct 17. doi: 10.1002/cncr.34496.
    PubMed     Abstract available
    
    
    
14. DUSKA LR
    Overcoming disparities to improve cancer care: The story of cervical cancer.
    Cancer. 2022 Oct 14. doi: 10.1002/cncr.34488.
    PubMed     Abstract available
    
    
    
15. VIKRAMAN SM, Khanna D, Dandpat A
    Cervical cancer elimination in indian context: Moving from barriers to facilitators.
    Cancer. 2022 Oct 14. doi: 10.1002/cncr.34486.
    PubMed     Abstract available
    
    
    
16. RIMEL BJ, Kunos CA, Macioce N, Temkin SM, et al
    Current gaps and opportunities in screening, prevention, and treatment of cervical cancer.
    Cancer. 2022 Oct 14. doi: 10.1002/cncr.34487.
    PubMed     Abstract available
    
    
    
17. MARKOVINA S, Rendle KA, Cohen AC, Kuroki LM, et al
    Improving cervical cancer survival-A multifaceted strategy to sustain progress for this global problem.
    Cancer. 2022 Oct 14. doi: 10.1002/cncr.34485.
    PubMed     Abstract available
    
    
    
18. O'ROURKE K
    First person profile: Robert C. Bast Jr MD: As an ovarian cancer expert, Dr Bast has made history by identifying cancer antigen 125, and he has shared his knowledge by mentoring the next generation of physicians: As an ovarian cancer expert, Dr Bast h
    Cancer. 2022;128:3431-3432.
    PubMed    
    
    
    August 2022
19. MCDANIELS-DAVIDSON C, Feng CH, Martinez ME, Canchola AJ, et al
    Improved survival in cervical cancer patients receiving care at National Cancer Institute-designated cancer centers.
    Cancer. 2022 Aug 2. doi: 10.1002/cncr.34404.
    PubMed     Abstract available
    
    
    July 2022
20. MOUKARZEL LA, Ferrando L, Stylianou A, Lobaugh S, et al
    Impact of obesity and white adipose tissue inflammation on the omental microenvironment in endometrial cancer.
    Cancer. 2022 Jul 6. doi: 10.1002/cncr.34356.
    PubMed     Abstract available
    
    
    June 2022
21. RAUH-HAIN JA, Zubizarreta J, Nitecki R, Melamed A, et al
    Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: A population-based study.
    Cancer. 2022 Jun 29. doi: 10.1002/cncr.34371.
    PubMed     Abstract available
    
    
    
22. MARTH C, Abreu MH, Andersen KK, Aro KM, et al
    Real-life data on treatment and outcomes in advanced ovarian cancer: An observational, multinational cohort study (RESPONSE trial).
    Cancer. 2022 Jun 17. doi: 10.1002/cncr.34350.
    PubMed     Abstract available
    
    
    
23. JAMIESON A, Barroilhet LM, McAlpine JN
    Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape.
    Cancer. 2022 Jun 3. doi: 10.1002/cncr.34328.
    PubMed     Abstract available
    
    
    
24. O'ROURKE K
    Cemiplimab shines for recurrent cervical cancer.
    Cancer. 2022;128:2050-2051.
    PubMed    
    
    
    
25. JOUNG RH, Nelson H, Mullett TW, Kurtzman SH, et al
    A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Cancer. 2022;128:2119-2125.
    PubMed     Abstract available
    
    
    May 2022
26. NERO C, Pasciuto T, Cappuccio S, Corrado G, et al
    Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score-matched analysis.
    Cancer. 2022 May 26. doi: 10.1002/cncr.34331.
    PubMed     Abstract available
    
    
    
27. STENZEL AE, Bustamante G, Sarkin CA, Harripersaud K, et al
    The intersection of sexual orientation with race and ethnicity in cervical cancer screening.
    Cancer. 2022 May 16. doi: 10.1002/cncr.34213.
    PubMed     Abstract available
    
    
    
28. O'ROURKE K
    Pembrolizumab is effective for endometrial cancer.
    Cancer. 2022;128:1886-1887.
    PubMed    
    
    
    April 2022
29. O'ROURKE K
    Better HPV vaccination and cervical cancer screening needed.
    Cancer. 2022;128:1559.
    PubMed    
    
    
    February 2022
30. EKANAYAKE WEERAMANGE C, Shu D, Tang KD, Batra J, et al
    Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Cancer. 2022 Feb 17. doi: 10.1002/cncr.34148.
    PubMed     Abstract available
    
    
    
31. LU E, Hatchell KE, Nielsen SM, Esplin ED, et al
    Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing.
    Cancer. 2022;128:675-684.
    PubMed     Abstract available
    
    
    January 2022
32. HENDERSON TO, Fowler BW, Hamann HA, Nathan PC, et al
    Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor.
    Cancer. 2022;128:373-382.
    PubMed     Abstract available
    
    
    
33. ARUN BK, Peterson SK, Sweeney LE, Bluebond RD, et al
    Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
    Cancer. 2022;128:94-102.
    PubMed     Abstract available
    
    
    December 2021
34. MCBRIDE CM, Pathak S, Johnson CE, Alberg AJ, et al
    Psychosocial factors associated with genetic testing status among African American women with ovarian cancer: Results from the African American Cancer Epidemiology Study.
    Cancer. 2021 Dec 9. doi: 10.1002/cncr.34053.
    PubMed     Abstract available
    
    
    
35. BELLONE S, Roque DM, Siegel ER, Buza N, et al
    A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
    Cancer. 2021 Dec 7. doi: 10.1002/cncr.34025.
    PubMed     Abstract available
    
    
    
36. ANTILL Y, Buchanan DD, Scott CL
    Mismatch repair and clinical response to immune checkpoint inhibitors in endometrial cancer.
    Cancer. 2021 Dec 7. doi: 10.1002/cncr.34024.
    PubMed     Abstract available
    
    
    
37. MOMTAZ P, O'Connor CA, Chou JF, Capanu M, et al
    Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes.
    Cancer. 2021;127:4393-4402.
    PubMed     Abstract available
    
    
    November 2021
38. PEI J, Li M, Wu C, Xu M, et al
    Worldwide trends in cervical cancer incidence and mortality.
    Cancer. 2021 Nov 24. doi: 10.1002/cncr.34029.
    PubMed    
    
    
    
39. LIN S, Gao K, Jin M
    Reply to Worldwide trends in cervical cancer incidence and mortality.
    Cancer. 2021 Nov 24. doi: 10.1002/cncr.34031.
    PubMed    
    
    
    
40. TEMKIN SM, Smeltzer MP, Dawkins MD, Boehmer LM, et al
    Improving the quality of care for patients with advanced epithelial ovarian cancer: Program components, implementation barriers, and recommendations.
    Cancer. 2021 Nov 17. doi: 10.1002/cncr.34023.
    PubMed     Abstract available
    
    
    
41. DESAI S, Zhu MJ, Lapidos-Salaiz I
    Cervical cancer prevention: Human papillomavirus testing as primary screening.
    Cancer. 2021 Nov 12. doi: 10.1002/cncr.34006.
    PubMed     Abstract available
    
    
    October 2021
42. DIN HN, Strong D, Singh-Carlson S, Corliss HL, et al
    Association between pregnancy intention and preconception health behaviors.
    Cancer. 2021 Oct 11. doi: 10.1002/cncr.33958.
    PubMed     Abstract available
    
    
    
43. BRANDT HM, Kepka D, Kirchhoff AC, Daniel CL, et al
    Human papillomavirus (HPV) vaccination is cancer prevention for childhood cancer survivors.
    Cancer. 2021 Oct 4. doi: 10.1002/cncr.33920.
    PubMed    
    
    
    
44. NIERENGARTEN MB
    Rucaparib is a safe and effective maintenance therapy for advanced pancreatic cancer.
    Cancer. 2021;127:3498.
    PubMed    
    
    
    
45. PINATTI LM, Gu W, Wang Y, Elhossiny A, et al
    SearcHPV: A novel approach to identify and assemble human papillomavirus-host genomic integration events in cancer.
    Cancer. 2021;127:3531-3540.
    PubMed     Abstract available
    
    
    September 2021
46. KOTSOPOULOS J, Kim SJ, Armel S, Bordeleau L, et al
    An evaluation of memory and attention in BRCA mutation carriers using an online cognitive assessment tool.
    Cancer. 2021;127:3183-3193.
    PubMed     Abstract available
    
    
    August 2021
47. SCHAEFER IM, Lundberg MZ, Demicco EG, Przybyl J, et al
    Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas.
    Cancer. 2021;127:2666-2673.
    PubMed     Abstract available
    
    
    June 2021
48. MAKHNOON S, Tran G, Levin B, Mattie KD, et al
    Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes.
    Cancer. 2021 Jun 22. doi: 10.1002/cncr.33668.
    PubMed     Abstract available
    
    
    March 2021
49. BALACHANDRA S, Kusin SB, Lee R, Blackwell JM, et al
    Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
    Cancer. 2021;127:850-864.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: